Grants per year
Personal profile
Research Interests
Neurovascular Critical Care, Stroke, Stroke of unknown cause, stroke in young people, acute stroke therapy, atrial fibrillation, stem cell therapy for stroke.
Certifications and Licenses
Vascular Neurology | |
Neurology |
Training Experience
1997 | Internship, Mount Sinai Hospital, Illinois |
2000 | Residency, New York Presbyterian Hospital |
2001 | Fellowship, Univ. of CA-San Francisco Med. Ctr. |
Education/Academic qualification
MD, PhD, Cornell University Medical College
… → 1996
Research interests
- Stroke
Fingerprint
- 7 Similar Profiles
Network
Grants
-
-
Stroke Trials Network - Regional Coordinating Stroke Centers
Bernstein, R. A., Prabhakaran, S. & Roth, E. J.
National Institute of Neurological Disorders and Stroke
8/1/16 → 7/31/18
Project: Research project
-
Protocol #1160-189: Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, oral b.i.d.) Versus Acetylsalicylic Acid (100 mg oral q.d.) in
Bernstein, R. A. & Caprio, F. Z.
Boehringer Ingelheim Pharmaceuticals, Inc.
8/21/15 → 8/21/19
Project: Research project
-
A Phase III, Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0 g Idarucizumab (BI 655075) in Patients Treated with Dabigatran Etexilate who have Uncontrolled Bleeding or Require Emer
Boehringer Ingelheim Pharmaceuticals, Inc.
4/6/15 → 4/6/18
Project: Research project
-
Study # D5134C00001: A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA [SOCRATES –Acute Stroke Or Transient IsChaemic Attack TReAted wi
AstraZeneca Pharmaceuticals LP
4/23/14 → 4/22/17
Project: Research project
Research Output
-
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups
Diener, H. C., Sacco, R. L., Easton, J. D., Granger, C. B., Bar, M., Bernstein, R. A., Brainin, M., Brueckmann, M., Cronin, L., Donnan, G., Gdovinová, Z., Grauer, C., Kleine, E., Kleinig, T. J., Lyrer, P., Martins, S., Meyerhoff, J., Milling, T., Pfeilschifter, W., Poli, S. & 4 others, , 2020, (Accepted/In press) In: Stroke. p. 1758-1765 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants
Hospital Quality Foundation, Jun 2020, In: American Journal of Emergency Medicine. 38, 6, p. 1163-1170 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis
Farrant, M., Easton, J. D., Adelman, E. E., Cucchiara, B. L., Barsan, W. G., Tillman, H. J., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zhao, W., Pauls, K., Walsh, K. B., Martí-Fàbregas, J., Bernstein, R. A. & Johnston, S. C., Sep 4 2019, In: JAMA network open. 2, 9, p. e1910769Research output: Contribution to journal › Article › peer-review
Open Access -
Dabigatran for prevention of stroke after embolic stroke of undetermined source
Diener, H. C., Sacco, R. L., Donald Easton, J., Granger, C. B., Bernstein, R. A., Uchiyama, S., Kreuzer, J., Cronin, L., Cotton, D., Grauer, C., Brueckmann, M., Chernyatina, M., Donnan, G., Ferro, J. M., Grond, M., Kallmünzer, B., Krupinski, J., Lee, B. C., Lemmens, R., Masjuan, J. & 5 others, , May 16 2019, In: New England Journal of Medicine. 380, 20, p. 1906-1917 12 p.Research output: Contribution to journal › Article › peer-review
141 Scopus citations -
Evaluation of the effect of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial
on behalf of the EMPEROR-Reduced Trial Committees and Investigators, Executive Committee, National Coordinators, Consulting Statistician, Clinical Events Committee, Scientific Excellence Committee & Data Monitoring Committee, Oct 1 2019, In: European Journal of Heart Failure. 21, 10, p. 1270-1278 9 p.Research output: Contribution to journal › Article › peer-review
Open Access29 Scopus citations